NTAP vs NVAX · P/E 28, rev $6.24B vs P/E 2.5, rev $196.2M
NetApp Inc (NTAP) versus Novavax Inc (NVAX) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Novavax Inc (NVAX) is a biotechnology company listed on US.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Not investment advice. Open the NTAP and NVAX stock pages for the full models.
Not investment advice.